Seoul, South Korea

Young-Ju Ha

This inventor holds 1 USPTO granted patent. Top assignee: Green Cross Vaccine Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young-Ju Ha. Retrieved from https://idiyas.com/inventor/young-ju-ha-nyfnozvn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Young-Ju Ha in Diabetes Research

Introduction

Young-Ju Ha is a notable inventor based in Seoul, South Korea. He has made significant contributions to diabetes research, particularly through his work at Green Cross Vaccine Corporation. With one patented invention to his name, Ha is making strides in understanding diabetes-related health issues.

Latest Patents

Young-Ju Ha holds a patent for "DNA and peptides of a diabetes-specific endogenous retrovirus." This innovative concept aims to provide insights into diabetes pathology, potentially paving the way for new therapeutic approaches.

Career Highlights

Ha's career is marked by his dedication to advancing the field of immunology and infectious diseases. As a part of Green Cross Vaccine Corporation, he actively engages in pioneering research that seeks to improve public health outcomes.

Collaborations

During his tenure at Green Cross Vaccine Corporation, Ha collaborates with esteemed colleagues, including Ji-Won Yoon and Hee-Sook Jun. Together, they work on various projects that aim to explore novel strategies for combating diabetes.

Conclusion

Young-Ju Ha is a promising inventor whose work in diabetes research highlights the importance of innovation in healthcare. His patent and collaborative efforts reflect his commitment to addressing significant health challenges through scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…